Optimizing Inhibitors That Fight Antibiotic Resistance

As strains of pathogens resistant to frontline antibiotics become more common worldwide, clinicians are more often turning to combination treatments that degrade this resistance as a first treatment option.

Researchers from Duke University have discovered the mechanism behind why some antibiotic-resistant pathogens haven't adapted to the combination treatments—the bacteria’s level of “selfishness.” The insight provides guidance to clinicians on how to best tailor these combination treatments to different pathogens, minimize the selection for resistance and formulate new antibiotic resistance inhibitors.  Source: Duke University Pratt School of Engineering